A citation-based method for searching scientific literature

Piotr Gałecki, Elżbieta Gałecka, Michael Maes, Marcelina Chamielec, Agata Orzechowska, Kinga Bobińska, Andrzej Lewiński, Janusz Szemraj. J Affect Disord 2012
Times Cited: 81







List of co-cited articles
1205 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
32



The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
511
23

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
22

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
22

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression.
Michael Maes, Marta Kubera, Ivana Mihaylova, Michel Geffard, Piotr Galecki, Jean-Clude Leunis, Michael Berk. J Affect Disord 2013
64
26


Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
238
19

Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
688
19



Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
18

Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness.
M Maes, N De Vos, R Pioli, P Demedts, A Wauters, H Neels, A Christophe. J Affect Disord 2000
194
17


Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.
Michael Maes, Michael Berk, Lisa Goehler, Cai Song, George Anderson, Piotr Gałecki, Brian Leonard. BMC Med 2012
302
17


Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
750
14

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
543
14

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.
M Maes, A Christophe, J Delanghe, C Altamura, H Neels, H Y Meltzer. Psychiatry Res 1999
327
14

Oxidative & nitrosative stress in depression: why so much stress?
Steven Moylan, Michael Berk, Olivia M Dean, Yuval Samuni, Lana J Williams, Adrienne O'Neil, Amie C Hayley, Julie A Pasco, George Anderson, Felice N Jacka,[...]. Neurosci Biobehav Rev 2014
222
14


The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.
Michael Maes, Raz Yirmyia, Jens Noraberg, Stefan Brene, Joe Hibbeln, Giulia Perini, Marta Kubera, Petr Bob, Bernard Lerer, Mario Maj. Metab Brain Dis 2009
554
13


Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.
Suchet D Khanzode, Ganesh N Dakhale, Shruti S Khanzode, Anand Saoji, R Palasodkar. Redox Rep 2003
294
13

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
185
13


Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
M Berk, F Kapczinski, A C Andreazza, O M Dean, F Giorlando, M Maes, M Yücel, C S Gama, S Dodd, B Dean,[...]. Neurosci Biobehav Rev 2011
742
12

Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.
Michael Maes, Marta Kubera, Ewa Obuchowiczwa, Lisa Goehler, Joanna Brzeszcz. Neuro Endocrinol Lett 2011
204
12

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments.
M Bilici, H Efe, M A Köroğlu, H A Uydu, M Bekaroğlu, O Değer. J Affect Disord 2001
490
12


Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
12

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
859
12

A Meta-Analysis of Oxidative Stress Markers in Depression.
Tao Liu, Shuming Zhong, Xiaoxiao Liao, Jian Chen, Tingting He, Shunkai Lai, Yanbin Jia. PLoS One 2015
167
12



Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.
Asli Sarandol, Emre Sarandol, Salih Saygin Eker, Selda Erdinc, Ebru Vatansever, Selcuk Kirli. Hum Psychopharmacol 2007
323
11

Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment.
Hasan Herken, Ahmet Gurel, Salih Selek, Ferah Armutcu, Murat Eren Ozen, Mahmut Bulut, Ozlem Kap, Mehmet Yumru, Haluk Asuman Savas, Omer Akyol. Arch Med Res 2007
206
11



Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
441
11



Th1, Th2, and Th3 cytokine alterations in major depression.
Aye-Mu Myint, Brian E Leonard, Harry W M Steinbusch, Yong-Ku Kim. J Affect Disord 2005
212
9

Increased plasma nitric oxide level associated with suicide attempt in depressive patients.
Yong-Ku Kim, Jong-Woo Paik, Sung-Woo Lee, Dokyung Yoon, Changsu Han, Bun-Hee Lee. Prog Neuropsychopharmacol Biol Psychiatry 2006
65
12

Elevated plasma nitrate levels in depressive states.
E Suzuki, G Yagi, T Nakaki, S Kanba, M Asai. J Affect Disord 2001
171
9

Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.
Kuan-Pin Su, Shih-Yi Huang, Cheng-Yuan Peng, Hsueh-Chou Lai, Chieh-Liang Huang, Yi-Chih Chen, Katherine J Aitchison, Carmine M Pariante. Biol Psychiatry 2010
119
9


Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
861
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.